Illumina, Warburg Pincus, and Sutter Hill Ventures formed Helix. Helix will enable individuals to acquire an unprecedented amount of genetic information by providing affordable sequencing and database services for consumer samples brought through third party partners, driving the creation of an ecosystem of consumer applications. “We are thrilled to partner with Illumina to transform how consumers interact with their own DNA,” said Noah Knauf, Managing Director, Healthcare at Warburg Pincus. “We believe that the digitization of the genome will unleash entrepreneurs and developers to create new applications for consumers in a way never before possible.”